{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T05:36:05Z","timestamp":1792906565210,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"vor","delay-in-days":6,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jtct.2026.07.004","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:50:35Z","timestamp":1791417035000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of Early Bloodstream Infections on Clinical Outcomes Following Allogeneic Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide-Based GVHD Prophylaxis"],"prefix":"10.1016","author":[{"given":"Moazzam","family":"Shahzad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Kashif","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amna Bint I","family":"Munir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shajadi","family":"Patan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shah","family":"Rukh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir Reza","family":"Akbari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aroog","family":"Khaliq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laiba","family":"Yaseen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Abdullah","family":"Humayun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amna","family":"Zaheer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anson E.","family":"Snow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Hamadani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"McGuirk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Umair","family":"Mushtaq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.jtct.2026.07.004_bib0001","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.bbmt.2016.04.019","article-title":"Allogeneic hematopoietic cell transplantation as curative therapy for patients with non-hodgkin lymphoma: increasingly successful application to older patients","volume":"22","author":"Fenske","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2026.07.004_bib0002","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1007\/s12288-023-01645-2","article-title":"Incidence, risk factors and outcome of bloodstream infections in patients after hematopoietic stem-cell transplantation: a single center study","volume":"39","author":"Niyazi","year":"2023","journal-title":"Indian J Hematol Blood Transfus"},{"issue":"3","key":"10.1016\/j.jtct.2026.07.004_bib0003","doi-asserted-by":"crossref","first-page":"742","DOI":"10.3390\/microorganisms11030742","article-title":"Bacterial bloodstream infections after allogeneic hematopoietic stem cell transplantation: etiology, risk factors and outcome in a single-center study","volume":"11","author":"Gill","year":"2023","journal-title":"Microorganisms"},{"issue":"1","key":"10.1016\/j.jtct.2026.07.004_bib0004","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.18668","article-title":"Incidence, risk factors, and outcomes of patients who develop mucosal barrier injury\u2013laboratory confirmed bloodstream infections in the first 100 days after allogeneic hematopoietic stem cell transplant","volume":"3","author":"Dandoy","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"9","key":"10.1016\/j.jtct.2026.07.004_bib0005","doi-asserted-by":"crossref","first-page":"776.e1","DOI":"10.1016\/j.jtct.2021.05.023","article-title":"Posttransplantation cyclophosphamide- and sirolimus-based graft-versus-host-disease prophylaxis in allogeneic stem cell transplant","volume":"27","author":"Greco","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2026.07.004_bib0006","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41409-019-0547-8","article-title":"Post-transplantation cyclophosphamide use in matched HLA donors: a review of literature and future application","volume":"55","author":"El Fakih","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2026.07.004_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2023.101092","article-title":"Does PTCY increase the risk of infections?","volume":"62","author":"Mikulska","year":"2023","journal-title":"Blood Rev"},{"issue":"6","key":"10.1016\/j.jtct.2026.07.004_bib0008","doi-asserted-by":"crossref","first-page":"520","DOI":"10.6004\/jadpro.2023.14.6.5","article-title":"Post-transplant cyclophosphamide for the prevention of graft-vs.-host disease in allogeneic hematopoietic cell transplantation: a guide to management for the advanced practitioner","volume":"14","author":"Kachur","year":"2023","journal-title":"J Adv Pract Oncol"},{"key":"10.1016\/j.jtct.2026.07.004_bib0009","series-title":"National Healthcare Safety Network (NHSN) Patient Safety Component Manual: Bloodstream Infection Event (Central Line-Associated Bloodstream Infection and Non-Central line-Associated BSI)","year":"2023"},{"key":"10.1016\/j.jtct.2026.07.004_bib0010","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41409-022-01851-y","article-title":"Bloodstream infections in allogeneic haematopoietic cell recipients from the swiss transplant cohort study: trends of causative pathogens and resistance rates","volume":"58","author":"Sava","year":"2023","journal-title":"Bone Marrow Transplant"},{"issue":"11","key":"10.1016\/j.jtct.2026.07.004_bib0011","doi-asserted-by":"crossref","first-page":"ofaa465","DOI":"10.1093\/ofid\/ofaa465","article-title":"Microbiology of bloodstream infections in children after hematopoietic stem cell transplantation: a single-center experience over two decades (1997-2017)","volume":"7","author":"Heston","year":"2020","journal-title":"Open Forum Infect Dis"},{"issue":"4","key":"10.1016\/j.jtct.2026.07.004_bib0012","doi-asserted-by":"crossref","first-page":"209.e1","DOI":"10.1016\/j.jtct.2021.12.020","article-title":"Risk and predictive factors for Candidemia after allogeneic hematopoietic cell transplantation: JSTCT transplant complications working group","volume":"28","author":"Kimura","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2026.07.004_bib0013","doi-asserted-by":"crossref","first-page":"5375","DOI":"10.2147\/IDR.S420310","article-title":"Microbiology and clinical outcome of bloodstream infections in patients after hematopoietic stem cell transplantation","volume":"16","author":"Song","year":"2023","journal-title":"Infect Drug Resist"},{"issue":"6","key":"10.1016\/j.jtct.2026.07.004_bib0014","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1093\/cid\/ciac004","article-title":"Attributable mortality of Candida bloodstream infections in the modern era: a propensity score analysis","volume":"75","author":"Mazi","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.jtct.2026.07.004_bib0015","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/MOH.0000000000000616","article-title":"Update in clinical and mouse microbiota research in allogeneic haematopoietic cell transplantation","volume":"27","author":"Lindner","year":"2020","journal-title":"Curr Opin Hematol"},{"issue":"8023","key":"10.1016\/j.jtct.2026.07.004_bib0016","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/s41586-024-07667-8","article-title":"An enterococcal phage-derived enzyme suppresses graft-versus-host disease","volume":"632","author":"Fujimoto","year":"2024","journal-title":"Nature"},{"issue":"suppl 6","key":"10.1016\/j.jtct.2026.07.004_bib0017","doi-asserted-by":"crossref","first-page":"S208","DOI":"10.1016\/j.htct.2024.05.009","article-title":"Early bacteremia following allogeneic hematopoietic stem cell transplantation without antibiotic prophylaxis: epidemiology and antimicrobial resistance","volume":"46","author":"Abdeljelil","year":"2024","journal-title":"Hematol Transfus Cell Ther"},{"issue":"4","key":"10.1016\/j.jtct.2026.07.004_bib0018","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1002\/iid3.486","article-title":"Are hematopoietic cell transplant recipients with gram-negative bacteremia spending more time outpatient while on intravenous antibiotics?","volume":"9","author":"Lind","year":"2021","journal-title":"Immun Inflamm Dis"},{"issue":"8","key":"10.1016\/j.jtct.2026.07.004_bib0019","doi-asserted-by":"crossref","first-page":"596.e1","DOI":"10.1016\/j.jtct.2025.05.007","article-title":"Bloodstream infections due to multidrug-resistant gram-negative organisms in hematopoietic stem cell transplant recipients: a multicenter case-control study in a high-prevalence area","volume":"31","author":"Palla","year":"2025","journal-title":"Transplant Cell Ther"},{"issue":"11","key":"10.1016\/j.jtct.2026.07.004_bib0020","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1093\/cid\/cix646","article-title":"Antimicrobial resistance in gram-negative rods causing bacteremia in hematopoietic stem cell transplant recipients: intercontinental prospective study","volume":"65","author":"Averbuch","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.jtct.2026.07.004_bib0021","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1093\/cid\/cis550","article-title":"Enterococcal bacteremia is associated with increased risk of mortality in recipients of allogeneic hematopoietic stem cell transplantation","volume":"55","author":"Vydra","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.jtct.2026.07.004_bib0022","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.bbmt.2020.01.019","article-title":"Enterococcus: a predictor of ravaged microbiota and poor prognosis after allogeneic hematopoietic stem cell transplantation","volume":"26","author":"Kusakabe","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6469","key":"10.1016\/j.jtct.2026.07.004_bib0023","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1126\/science.aax3760","article-title":"Lactose drives Enterococcus expansion to promote graft-versus-host disease","volume":"366","author":"Stein-Thoeringer","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.jtct.2026.07.004_bib0024","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.713631","article-title":"Novel insights into the mechanism of GVHD-induced tissue damage","volume":"12","author":"Ara","year":"2021","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.jtct.2026.07.004_bib0025","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/s41409-024-02474-1","article-title":"Immunological reconstitution and infections after alloHCT \u2013 a comparison between post-transplantation cyclophosphamide, ATLG and non-ATLG based GvHD prophylaxis","volume":"60","author":"Meyer","year":"2025","journal-title":"Bone Marrow Transplant"},{"issue":"7","key":"10.1016\/j.jtct.2026.07.004_bib0026","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.3390\/cancers17071109","article-title":"Post-transplant cyclophosphamide-based prophylaxis and its impact on infectious complications and immune reconstitution according to donor type","volume":"17","author":"Merch\u00e1n-Mu\u00f1oz","year":"2025","journal-title":"Cancers (Basel)"},{"issue":"9","key":"10.1016\/j.jtct.2026.07.004_bib0027","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.27231","article-title":"Associations between neutrophil recovery time, infections and relapse in pediatric acute myeloid leukemia","volume":"65","author":"L\u00f8hmann","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jtct.2026.07.004_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtct.2025.05.027","article-title":"Incidence, risk factors, and outcomes of bloodstream infection during conditioning phase before allogeneic hematopoietic stem cell transplantation","author":"Pan","year":"2025","journal-title":"Transplant Cell Ther"},{"issue":"8","key":"10.1016\/j.jtct.2026.07.004_bib0029","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1182\/bloodadvances.2017014464","article-title":"Delayed immune reconstitution after allogeneic transplantation increases the risks of mortality and chronic GVHD","volume":"2","author":"Bejanyan","year":"2018","journal-title":"Blood Adv"},{"issue":"14","key":"10.1016\/j.jtct.2026.07.004_bib0030","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1182\/bloodadvances.2024015288","article-title":"Delayed T-cell recovery after hematopoietic cell transplantation is associated with decreased overall survival in adults","volume":"9","author":"Perales","year":"2025","journal-title":"Blood Adv"},{"issue":"suppl_2","key":"10.1016\/j.jtct.2026.07.004_bib0031","doi-asserted-by":"crossref","first-page":"S162","DOI":"10.1093\/cid\/ciy658","article-title":"Incidence, risk factors, microbiology and outcomes of pre-engraftment bloodstream infection after haploidentical hematopoietic stem cell transplantation and comparison with HLA-identical sibling transplantation","volume":"67","author":"Yan","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"19","key":"10.1016\/j.jtct.2026.07.004_bib0032","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000042317","article-title":"Prophylactic fluoroquinolones in hematopoietic stem cell transplant recipients: a meta-analytic comparison of ciprofloxacin and levofloxacin","volume":"104","author":"Albalawi","year":"2025","journal-title":"Medicine"},{"issue":"1","key":"10.1016\/j.jtct.2026.07.004_bib0033","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13145","article-title":"Ciprofloxacin vs levofloxacin for prophylaxis during hematopoietic stem-cell transplantation","volume":"32","author":"Copeland","year":"2017","journal-title":"Clin Transplant"},{"issue":"5","key":"10.1016\/j.jtct.2026.07.004_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(24)00749-7","article-title":"Global guideline for the diagnosis and management of candidiasis: an initiative of the ECMM in cooperation with ISHAM and ASM","volume":"25","author":"Cornely","year":"2025","journal-title":"Lancet Infect Dis"},{"issue":"12","key":"10.1016\/j.jtct.2026.07.004_bib0035","doi-asserted-by":"crossref","first-page":"850.e1","DOI":"10.1016\/j.jtct.2022.09.001","article-title":"Bacterial bloodstream infections in patients undergoing allogeneic hematopoietic cell transplantation with post-transplantation cyclophosphamide","volume":"28","author":"Salas","year":"2022","journal-title":"Transplant Cell Ther"},{"issue":"1","key":"10.1016\/j.jtct.2026.07.004_bib0036","doi-asserted-by":"crossref","first-page":"96.e1","DOI":"10.1016\/j.jtct.2025.09.019","article-title":"Bacterial bloodstream infections after hematopoietic cell transplantation with post-transplant cyclophosphamide","volume":"32","author":"Chor\u00e3o","year":"2026","journal-title":"Transplant Cell Ther"},{"issue":"11","key":"10.1016\/j.jtct.2026.07.004_bib0037","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1093\/cid\/cix690","article-title":"Incidence, risk factors and outcome of pre-engraftment gram-negative bacteremia after allogeneic and autologous hematopoietic stem cell transplantation: an Italian Prospective Multicenter Survey","volume":"65","author":"Girmenia","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.jtct.2026.07.004_bib0038","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.bbmt.2020.01.013","article-title":"Infections after allogenic transplant with post-transplant cyclophosphamide: impact of donor HLA matching","volume":"26","author":"Oltolini","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"10.1016\/j.jtct.2026.07.004_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2025.106571","article-title":"Epidemiology of resistant bacterial infections in patients with hematological malignancies or undergoing hematopoietic cell transplantation in Europe: a systematic review by the European conference on infections in leukemia (ECIL)","volume":"91","author":"Baccelli","year":"2025","journal-title":"J Infect"},{"issue":"1","key":"10.1016\/j.jtct.2026.07.004_bib0040","doi-asserted-by":"crossref","first-page":"50.e1","DOI":"10.1016\/j.jtct.2021.10.008","article-title":"Bloodstream infections and outcomes following allogeneic hematopoietic cell transplantation: a single-center study","volume":"28","author":"Carreira","year":"2022","journal-title":"Transplant Cell Ther"},{"issue":"7","key":"10.1016\/j.jtct.2026.07.004_bib0041","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.154344","article-title":"Microbiota dynamics in a randomized trial of gut decontamination during allogeneic hematopoietic cell transplantation","volume":"7","author":"Severyn","year":"2022","journal-title":"JCI Insight"},{"issue":"10","key":"10.1016\/j.jtct.2026.07.004_bib0042","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.bbmt.2009.06.019","article-title":"Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective","volume":"15","author":"Tomblyn","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"10.1016\/j.jtct.2026.07.004_bib0043","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/tid.12176","article-title":"Bloodstream and central line isolates from hematopoietic stem cell transplant recipients: data from a developing country","volume":"16","author":"Ali","year":"2014","journal-title":"Transpl Infect Dis"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636726005385?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636726005385?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T05:02:46Z","timestamp":1792904566000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636726005385"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":43,"alternative-id":["S2666636726005385"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2026.07.004","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of Early Bloodstream Infections on Clinical Outcomes Following Allogeneic Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide-Based GVHD Prophylaxis","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2026.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of American Society for Transplantation and Cellular Therapy.","name":"copyright","label":"Copyright"}]}}